Deviation & Failure Case Studies – Page 17

Cleaning SOP deviation ignored during multi-product manufacturing – regulatory observation analysis

The first indications of a cleaning SOP deviation typically manifest as unexpected results during routine testing or product quality assessments. In this case, the symptoms included:Click to read the full…

Carryover detected post-cleaning during multi-product manufacturing – regulatory observation analysis

The initial identification of the carryover issue occurred during a routine quality control (QC) inspection, where analysts observed unexpected results in a batch of a new product following the cleaning…

Worst-case selection unjustified during investigation – cross-contamination risk case study

Effective detection of deviations often relies on an observant workforce and robust quality monitoring systems. In this case, several symptoms became apparent:Click to read the full article.

Visual cleanliness accepted without testing during investigation – revalidation CAPA failure

The first indication of a potential issue came from unexpected results in routine batch testing, leading to increased out-of-specification (OOS) findings. Operators noted that cleaning logs showed discrepancies and an…

Visual cleanliness accepted without testing during investigation – cross-contamination risk case study

During routine batch release documentation, the Quality Control (QC) team noted discrepancies in product results that raised concerns over potential contamination. Symptoms included:Click to read the full article.

Cleaning validation not updated after product change during inspection – revalidation CAPA failure

During a routine FDA inspection, significant concerns were raised regarding the cleaning validation processes following a recent product change. Key indicators included:Click to read the full article.

Cleaning validation not updated after product change during inspection – cross-contamination risk case study

The initial indications of the issue arose during routine batch sampling at PharmaCorp's manufacturing site. QC analysts observed unexpected residual matter on equipment used for a newly introduced product line.…

Carryover detected post-cleaning during equipment changeover – revalidation CAPA failure

The first indication of a carryover issue often arises through product inspections or analytical testing. In this case study, the symptoms manifested as unexpected residual concentrations of an active pharmaceutical…

Carryover detected post-cleaning during investigation – cross-contamination risk case study

The discovery of carryover post-cleaning manifested through an unexpected finding during a quality control testing phase. Specifically, a product batch manufactured after a previous run unexpectedly showed trace contamination of…

Worst-case selection unjustified during investigation – revalidation CAPA failure

The initial signs of a potential issue often emerge as unexpected discrepancies in routine cleaning validation of manufacturing equipment. In this case, operators noticed that the indicator cleaning results in…

Carryover detected post-cleaning during inspection – regulatory observation analysis

During a scheduled internal audit, cleaning validation logs indicated a failure to meet the acceptable residue limits for an active pharmaceutical ingredient (API) after a cleaning cycle. The following symptoms…

Cleaning validation not updated after product change during equipment changeover – revalidation CAPA failure

Failed Cleaning Validation Post Equipment Change: A Case Study in CAPA Management In pharmaceutical manufacturing, maintaining compliance with Good Manufacturing Practices (GMP) is critical for ensuring product quality and patient…